300 companies
HARP
Harpoon Therapeutics Inc
harpoon therapeutics is a pre-clinical stage biotechnology company co-founded by patrick bauerle, a pioneer in t-cell engagement, and luke evnin (mpm capital) in 2015 to develop and commercialize a novel class of t cell recruiting antibodies engage a patient’s own immune cells to fight cancer and other diseases.
California
NASDAQ
Henri A Termeer
Henry E Blair
Higgins Arthur J
HLVX
HilleVax Inc
hillevax is a biopharmaceutical company focused on the development and commercialization of novel vaccines.
Massachusetts
NASDAQ
HUMA
Humacyte Inc
biotechnology company
North Carolina
NASDAQ
INAB
IN8bio Inc
in8bio, inc.
New York
NASDAQ
INMB
INmune Bio Inc
inmune bio inc.
Florida
NASDAQ
ITOS
ITeos Therapeutics Inc
starting operations in 2012, iteos therapeutics is a clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by developing immunotherapies by design.
Massachusetts
NASDAQ
ICVX
Icosavax Inc
icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs.
Washington
NASDAQ
IKNA
Ikena Oncology Inc
ikena oncology (formerly kyn therapeutics) is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients, by understanding what drives their disease.
Massachusetts
NASDAQ
IMTX
Immatics N.V
immatics is a clinical-stage biopharmaceutical company active in the discovery and development of t-cell redirecting immunotherapies for the treatment of cancer.
Germany
NASDAQ
IBRX
ImmunityBio Inc
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system.
California
NASDAQ
IMCR
Immunocore Holdings plc
immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases.
United Kingdom
NASDAQ
IMVT
Immunovant Inc
immunovant, inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
New York
NASDAQ
Imreg Inc
IKT
Inhibikase Therapeutics Inc
inhibikase therapeutics, inc., a clinical stage pharmaceutical company, develops therapeutics for parkinson's disease, and related disorders that arise inside and outside of the brain.
Georgia
NASDAQ
Inhibrx Biosciences Inc.
INBX
Inhibrx Inc
development of antibodies
California
NASDAQ
IPHA
Innate Pharma
innate pharma s.a.
France
NASDAQ